ArticleAmerican journal of cancer research2022

Trastuzumab in combination with PEGylated interferon-α1b exerts synergistic antitumor activity through enhanced inhibition of HER2 downstream signaling and antibody-dependent cellular cytotoxicity.

Piaopiao Xu et al.PubMed ↗Full text ↗

No numbers read from the abstract.